11 days
Submission to first decision

Medical Oncology (MO) communicates the results of clinical and experimental research in oncology and hematology, particularly experimental therapeutics within the fields of immunotherapy and chemotherapy. It also provides state-of-the-art reviews on clinical and experimental therapies. Topics covered include immunobiology, pathogenesis, and treatment of malignant tumors.

Editor-in-Chief
Kenneth J. Pienta, MD, PhD
The Donald S. Coffey Professor of Urology, The John Hopkins Hospital; Baltimore, MD, USA
Managing Editor
David "Brandy" Yeater, MRA
The Johns Hopkins University, Brady Urological Institute, Baltimore, MD, USA
Associate Editors:
Rino Bellocco, Sc.D., Milan, Italy
David Waugh, PhD, Belfast, Northern Ireland
Sarah Amend, PhD, Baltimore, MD, USA
Liang Dong, MD, Shanghai, China
Editorial Board:
Esther Baena, PhD
Cancer Research UK Manchester Institute; Manchester, United Kingdom
Richard P. Baum, Prof. Dr. med 
Theranostics Center Zentralklinik; Bad Berka, Germany
Janice P. Dutcher, MD
New York Medical College; Bronx, NY, USA
Elisabeth I. Heath, MD
Karmanos Cancer Institute; Detroit, MI, USA
Paula Hurley, PhD
The Johns Hopkins University; Baltimore, MD, USA
Ezzeldin M. Ibrahim, MD
International Medical Center; Jeddah, Saudi Arabia
Christopher Maher, PhD
Washington University School of Medicine; St. Louis, MO, USA
Rohit Mehra, MD
University of Michigan Hospital and Health Systems; Ann Arbor, MI, USA
Kosuke Mizutani, MD, PhD
Gifu University Graduate School of Medicine; Gifu, Japan
Ray Panvichian, MD
Mahidol University; Bangkok, Thailand
Chan-Nan Qian, PhD
Van Andel Research Institute; Grand Rapids, MI, USA
Michael T. Schweizer, MD
University of Washington School of Medicine; Seattle, WA, USA
Yusuke Shiozawa, MD, PhD
Wake Forest University; Winston-Salem, NC, USA
Katerina Stankova, PhD
Maastricht University; Maastricht, The Netherlands